California’s Osseon Therapeutics Received FDA Allowance for VCF Compression Technology

Osseon Therapeutics, a Santa Rosa, Calif.-based biomedical device company, received the FDA notice of allowance for its spinal vertebral compression technology as part of its Osseoplasty systems, according to a company news release.

Advertisement

The first generation of Osseoplasty was approved in 2009 and Osseon has upgraded the system with VCF technology.

Read the news release on spinal vertebral compression technology.

Read more coverage on VCF technology:

– RF Kyphoplasty Shows Less Cement Leakage Than Vertebroplasty

– Stryker Interventional Spine Launches iVAS Inflatable Vertebral Augmentation System

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.